Company profile
NEWTON BIOCAPITAL
YOUR TRUSTED PARTNER FOR LIFE SCIENCES INVESTMENTS IN EUROPE & JAPAN
- Industry
- Venture Capital and Private Equity Principals
- Employees
- 16
- Headquarters
- Brussels
- Founded
- 2017
- Office locations
- 2
NEWTON BIOCAPITAL company summary
NEWTON BIOCAPITAL is a company in the Venture Capital and Private Equity Principals industry, headquartered in Brussels, founded in 2017. On LinkedIn the company has around 16 employees. The company lists 2 office locations.
What technology does NEWTON BIOCAPITAL use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NEWTON BIOCAPITAL
Newton Biocapital (NBC) is a VC firm focused on early-stage Life Sciences companies targeting chronic health conditions. NBC is among the 8 VC firms certified by AMED in Japan to boost the pharma ecosystem and the only one with offices in Japan/Europe. NBC’s diversified team of experts and its presence in Japan/Europe enable NBC to identify and select the most promising companies based on the outstanding research ecosystem in these two regions. NBC provides investment opportunities that can help patients and society, as well as foster growth of the Japanese/European biotech ecosystems. NBC is a hands-on investor and leverages its expertise to help its portfolio companies focus on the right indication and clinical trial design, thereby helping them progress successfully through the challenging early drug development phases up to the proof of concept in patients. NBC enables time- and cost-effective translation from science to proof of concept in patients that attracts potential acquirers and unlocks value – for patients, companies, and investors. Partner with us to unlock life sciences innovation, grow the biotech sectors and make an impact both locally and internationally.
Where is NEWTON BIOCAPITAL located?
NEWTON BIOCAPITAL lists 2 office locations.
Compare companies similar to NEWTON BIOCAPITAL
More companies in Venture Capital and Private Equity Principals.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NEWTON BIOCAPITAL newtonbiocapital.com | Venture Capital and Private Equity Principals | 16 | 2017 | Brussels |
 Sequoia Capital sequoiacap.com | Venture Capital and Private Equity Principals | 347 | - | Menlo Park, CA |
 Andreessen Horowitz a16z.com | Venture Capital and Private Equity Principals | 1,030 | 2009 | Menlo Park, CA |
 Private Equity Insights pe-insights.com | Venture Capital and Private Equity Principals | 1,579 | 2013 | London, England |
 500 Global 500.co | Venture Capital and Private Equity Principals | 2,686 | 2010 | Palo Alto, California, US |
 Techstars techstars.com | Venture Capital and Private Equity Principals | 2,610 | 2006 | New York City, New York |
 Accel accel.com | Venture Capital and Private Equity Principals | 1,411 | - | Palo Alto, CA |
 Virgin virgin.com | Venture Capital and Private Equity Principals | 36,222 | - | London, England |
 Conscience VC conscience.vc | Venture Capital and Private Equity Principals | 2,001 | 2020 | Austin, TX |
 Peak XV Partners peakxv.com | Venture Capital and Private Equity Principals | 206 | - | Bangalore, Karnataka, IN |
 Greylock Partners greylock.com | Venture Capital and Private Equity Principals | 132 | - | Menlo Park, CA, US |
Frequently asked questions about NEWTON BIOCAPITAL
What does NEWTON BIOCAPITAL do?
Newton Biocapital (NBC) is a VC firm focused on early-stage Life Sciences companies targeting chronic health conditions. NBC is among the 8 VC firms certified by AMED in Japan to boost the pharma ecosystem and the only one with offices in Japan/Europe. NBC’s diversified team of experts and its presence in Japan/Europe enable NBC to identify and select the most promising companies based on the outstanding research ecosystem in these two regions. NBC provides investment opportunities that can help patients and society, as well as foster growth of the Japanese/European biotech ecosystems. NBC is a hands-on investor and leverages its expertise to help its portfolio companies focus on the right indication and clinical trial design, thereby helping them progress successfully through the challenging early drug development phases up to the proof of concept in patients. NBC enables time- and cost-effective translation from science to proof of concept in patients that attracts potential acquirers and unlocks value – for patients, companies, and investors. Partner with us to unlock life sciences innovation, grow the biotech sectors and make an impact both locally and internationally.
How many employees does NEWTON BIOCAPITAL have?
NEWTON BIOCAPITAL has around 16 employees on LinkedIn.
Where is NEWTON BIOCAPITAL headquartered?
NEWTON BIOCAPITAL is headquartered in Brussels.
Where does NEWTON BIOCAPITAL have offices?
NEWTON BIOCAPITAL lists 2 office locations, including Brussels, 1150, BE; Tokyo, 103-0023, JP.
When was NEWTON BIOCAPITAL founded?
NEWTON BIOCAPITAL was founded in 2017.
Build a lead list from companies like NEWTON BIOCAPITAL
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.